Jasper Therapeutics Appoints Jeet Mahal As Interim Principal Financial Officer Effective October 9, 2026; Herb Cross Resigns As CFO Effective October 9, 2026
Benzinga Newsdesk 1 month ago
ManagementNews
On September 23, 2026, Herb Cross submitted his resignation, effective as of October 9, 2026, as Chief Financial Officer, Principal Financial Officer, Principal Accounting Officer and Corporate Secretary of Jasper
On September 23, 2026, Herb Cross submitted his resignation, effective as of October 9, 2026, as Chief Financial Officer, Principal Financial Officer, Principal Accounting Officer and Corporate Secretary of Jasper Therapeutics, Inc. (the "Company") in order to pursue other professional endeavors.
On September 28, 2026, the board of directors of the Company appointed Jeet Mahal, the Company’s President and Chief Executive Officer, as interim Principal Financial Officer, Rick Ruiz, the Company’s Vice President, Finance, as interim Principal Accounting Officer and Matthew Ros, the Company’s Chief Operating Officer, as the interim Corporate Secretary, each effective as of Mr. Cross’ resignation.